Summary-Dexamethasone, a synthetic glucocorticoid, decreases the plasminogen activator (PA) activity of HTC rat hepatoma cells in tissue culture. Paradoxically, dexamethasone enhances the cyclic nucleotide stimulation of PA activity in these cells 24-fold. In this report, we investigated whether this paradoxical glucocorticoid effect is mediated by the same proximal events which mediate such direct regulatory actions of glucocorticoids as the induction of tyrosine aminotransferase activity. We compared the concentrationdependences for several classes of steroids, previously classified as full agonists, partial agonists, antagonists or inactive steroids with respect to induction of the transaminase, for both enhancement of cyclic nucleotide stimulation of PA activity and induction of tyrosine aminotransferase activity in parallel cultures. The full agonists dexamethasone and cortisol, the partial agonists deoxycorticosterone and 1 Ifi-hydroxyprogesterone, the inactive steroid tetrahydrocortisol, and the antagonist I 'la-methyltestosterone exhibited similar potencies with respect to both phenomena. Furthermore, when cells were incubated with both dexamethasone and 17a-methyltestosterone, the latter blocked enhancement by dexamethasone in a concentration-dependent fashion. We conclude that glucocorticoid enhancement of cyclic nucleotide stimulation of PA activity is mediated by the same glucocorticoid receptors which mediate direct regulatory effects.
and effecters remain to be identified [9, 121. In this study, we measured the dose-response relationships of several classes of steroids for enhancement of cyclic nucleotide stimulation of PA activity and for induction of TAT activity in parallel cultures at 24 h, a time when both responses should be stable and maximal. Samuels and Tomkins [13] have previously classified steroids on the basis of their ability to induce TAT. Full agonists maximally induce the biological response; partial agonists, which also bind to the glucocorticoid receptor, induce the response suboptimally even at high concentrations; antagonists bind to the receptor, but fail to elicit a biological response; and, inactive steroids neither bind to the receptor nor elicit a response. We report here that these steroids exhibit the same relative potencies in the induction of TAT activity and enhancement of cyclic nucleotide stimulation of PA activity. Furthermore, the antagonist 17u -methyltestosterone blocks the enhancement by the agonist dexamethasone in a concentration-dependent manner. We conclude that the enhancement phenomenon is mediated by the same glucocorticoid receptors which mediate the direct actions of glucocorticoids.
MATERIALS AND METHODS

materials
Eagle's Minimal Essential Medium, calf and fetal bovine sera, glutamine, trypsin and neomycin were obtained from GIBCO Laboratories, Grand Island, New York. Dexamethasone (9x-fluoro16x-methyl-l 1~,17~,21-trihydroxy-1 ,Cpregnadiene-3,20-dione) was a gift from Dr Walter Gall of Merck & Co. Cortisol (11&17a, , deoxycorticosterone(21-hydroxy-Cpregnene-3,20-dione), 1 lj?-hydroxyprogesterone (1 lphydroxy-4-pregnene-3,20-dione), tetrahydrocortisol (3x, 11~,17a,21-tetrahydroxy-SP-pregnan -20-one), and 17a -methyltestosterone (17~ -methyl -178 -hydroxy-4-androsten-3-one)
were purchased from Steraloids Inc., Wilton, New Hampshire and were each reported to migrate as a single spot on thin layer chromatography.
Fibrinogen (98% clottable), 8-bromadenosine-3': S-cyclic monophosphoric acid and methylisobutylxanthine (MIBX) were obtained from Calb~ochem-Boeh~ng, San Diego, California. '251-labeled fibrinogen (sp. act. -150 mCi/g protein) was purchased from Amersham, Arlington Heights, Illinois. Plasminogen was purified from outdated human plasma by affinity chromatography [14] . All other compounds were of at least reagent grade.
Cell culture
HTC cells were grown in monolayer culture without antibiotics in Eagle's Minimal Essential Medium supplemented with 50 mM tricine (N-[Zhydroxy-I, Ibis(hydroxymethyl)ethyl]glycine), 0.5 g/l sodium bicarbonate, 2 mM glutamine, 0.02% caicium chloride, 5% calf serum and 5% fetal bovine serum.
Enzyme assays
Tyrosine aminotransferase (L-tyrosine: 2-0x0-glutarate aminotransferase, EC 2.6.1 S) activity was measured as previously described by Spencer and Gelehrter 1151. Plasminogen activator activity in cell extracts (in 0.2% Triton X-100) and in medium conditioned by the cells was determined by the plasminogen-dependent solubilization of '251-labeled fibrin coated on multiwell plates as described elsewhere [l, 161. Solubilized radioactivity was corrected for background release and then expressed as a percentage of the total radioactivity solubilized by 5O+ug trypsin. The various steroids, 8-Br-CAMP, MIBX, ethanol, and dimethyl sulfoxide did not alter either fibrinolytic activity or background release when added directly to the assay.
Clucocorticoid treatment of cells
Cells were plated at 1 to 2 x lOh cells/35 mm tissue culture dish in serum-supplemented medium. After the cells had grown to SO-900/, confluence, the monolayers were washed twice with serum-free medium and then incubated for 24 h at 37°C in serum-free medium containing O.lo/:, bovine serum albumin, 0.02% calcium chloride, 50 pg/ml neomycin and 8-Br-CAMP, MIBX and various steroids at the concentrations described in the 
RESULTS
Concentration de~ende~~ce ofdexamethaso~e ~~duct~o~ of TAT activity, i#h~bit~on of PA activity. and enhancement of 8-Br-cAMP stimulation of PA activity.
Initially, we examined the dose-response relationships for dexamethasone induction of TAT activity, inhibition of PA activity, and enhancement of cyclic nucleotide stimulation of PA activity. Inhibition of PA activity and induction of TAT activity were measured in the same cultures, as described in Materials and Methods; the enhancement phenomenon was examined in parallel cultures which contained 8-Br-CAMP and MIBX as well as dexamethasone. In this experiment, the concentrationdependence upon dexamethasone is virtually identical for all three phenomena (Fig. 1) . Half-maximal response was obtained at 4 nM dexamethasone, and maximal response at approx 20nM.
Steroid specificity oj' the induction of TA T activity and enha~eement of cyclic ~~cieotide st~mMiat~on qf PA activity
We measured the concentration-dependence of steroidal induction of TAT activity and enhancement of cyclic nucleotide stimulation of PA activity in parallel cultures after 24 h of incubation, a time when both effects should be stable and maxima1 (Fig. 2) 1 la-hydroxyprogesterone submaximally induced TAT activity. Deoxycorticosterone induced TAT to slightly higher levels than did 1 I/?-hydroxyprogesterone and was effective at lower concentrations. Neither the antagonist, 17a-methyltestosterone, nor the inactive steroid, tetrahydrocortisol, induced TAT activity.
Similar, although not identical, concentrationdependences were obtained for the enhancement phenomenon (Fig. 2B) . The full agonists, dexamethasone and cortisol, elicited maximal enhancement at the same relative potencies observed for the induction of TAT activity. Deoxycorticosterone and 1 l/j'-hydroxyprogesterone again behaved as partial agonists, enhancing cyclic nucleotide stimulation of PA activity to 50 to 60% of the maximal response. However, the concentrations required for halfmaximal enhancement by both full and partial agonists were somewhat lower than those required for half-maximal induction of TAT. Neither the antagonist nor the inactive steroid caused any enhancement of cyclic nucleotide stimulation.
Competitive interactions between steroids
Antagonists block the induction of TAT and the inhibition of amino acid transport by full agonists, presumably by competing for binding to the glucocorticoid receptor [13, 171. If enhancement is indeed mediated by glucocorticoid receptors, then the addition of 17a-methyltestosterone or progesterone should similarly block dexamethasone enhancement of stimulation of PA activity by CAMP derivatives. As illustrated in Fig. 3, 17cr -methyltestosterone does block the enhancement response elicited by dexamethasone in a concentration-dependent fashion. In the absence of dexamethasone, these concentrations of 17c(-methyltestosterone have no effect on PA activity.
Progesterone similarly blocks dexamethasone enhancement; However, at high concentrations ( 9 10 PM) in the absence of dexamethasone, progesterone itself enhances CAMP effects (data not shown). Similar anomalous effects of high concentrations of progesterone were observed on inhibition of amino acid transport in HTC cells [17] .
DISCUSSION
The concentration-dependence of the dexamethasone induction of tyrosine aminotransferase activity is directly correlated with the binding of
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deoxycorticosterone, ( n ) 11 fi-hydroxyprogesterone, (+) 17a-methyltestosterone, or (0) tetrahydrocortisol; TAT activity ( Fig. 2A) and both cellassociated and extracellular PA activity ( Maximal enhancement was 2-g-fold.
dexamethasone to cytoplasmic receptors, and with the nuclear binding of receptor-steroid complexes in HTC cells [S-S] . Furthermore, the concentrationdependences for the dexamethasone induction of tyrosine aminotransferase, alkaline phosphodiesterase I and cell adhesiveness, and the inhibition of amino acid transport and plasm~nogen activator activity are virtually identical ( Fig. 1 and Ref. 5-8, 17-2 1) consistent with these phenomena all being mediated by the same glucocorticoid receptors. Additional support for this view comes from studies of the steroid specificity of these effects using various classes of steroids including full agonists, partial agonists, antagonists and inactive steroids [ 13, 17,2 11. Similar observations have been made for direct glucocorticoid effects in other experimental systems [22] .
In contrast, the dose-response relationships for permissive or interactive effects of glucocorticoids with other hormones and effecters vary considerably. The concentration-dependence of the permissive effect of dexamethasone on dibutyryl CAMP induction of TAT in HTC cells is right-shifted relative to the concentration~e~ndence for direct giucocorticoid induction of TAT in these cells [9] . However, glucocorticoid inhibition of vasoactive intestinal peptide stimulation of CAMP accumulation and prolactin secretion in cultured rat pituitary cells occurs at picomolar concentrations and is glucocorticoidspecific [ 111.
In HTC cells, dexamethasone both inhibits PA activity and, paradoxically, enhances the stimulation of PA activity by cyclic nucfeotides. In this report, we have presented two lines of evidence that this paradoxical steroidal effect on cyclic nucleotide regulation of PA activity is mediated by glucocorticoid receptors. First, several classes of steroids exhibit similar potencies with respect to both induction of TAT and enhancement of cyclic nucleotide stimulation of PA. Second, the antagonist 17a-methyltestosterone blocks the enhancement by dexamethasone in a concentration-dependent manner. Although our data suggest that the paradoxical effects of dexamethasone on PA activity are mediated by glucocorticoid receptors, it should be noted that the enhancement of cyclic nucleotide stimulation of PA activity occurs at slightly lower concentrations of dexamethasone than does the induction of transaminase activity (Figs 2 and 3) . A similar leftward shift in concentration-dependence is also noted for cortisol and for the partial agonists deoxycorticosterone and I Ifi-hydroxyprogesterone (Fig. 2) . Mercier et a/. [23] have reported a similar, though even more striking, leftward shift in the concentration-dependence for a dexamethasoneinduced biological effect relative to binding of dexamethasone to glucocorticoid receptors. In FUS-5 rat hepatoma cells, the dose-response curve for dexamethasone induction of tyrosine aminotransferase is shifted to the left approx. 7-fold relative to that for dexamethasone binding to whole cells, and to that for induction of glutamine synthetase. The explanation for such discrepant dose-response relationships is not known, but the occurrence of such non-linear relationships between the concentration-dependence for glucocorticoid binding and biological action suggests greater complexity than that included in current models of glucocorticoid action [5,6, 8,221. 
